一个新型的受控释放系统Au-CuONP/P(MMAcoMAA) /奇托桑纳米复合材料:合成,表征,抗菌活性和在分子对接
Ecem Isiksel1, Azade Attar2, Lalehan Ozalp3
1Yildiz Technical University, Faculty of Science and Letters, Department of Chemistry, Davutpasa Campus, 34220 Istanbul, Turkey.
International journal of biological macromolecules
|March 13, 2025
概括
绿色合成的双金属金-铜氧化物 (Au-CuO) 纳米粒子被用于创建用于药物输送的新型纳米复合材料. 这些Au-CuO纳米复合材料具有显著的抗菌和抗真菌特性,以及可控释放能力.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
- 绿色化学 绿色化学
背景情况:
- 开发具有成本效益和环保的纳米材料用于药物输送至关重要.
- 双金属纳米颗粒为抗微生物应用提供了独特的特性.
- 植物提取物为纳米粒子合成提供了一个可持续的来源.
研究的目的:
- 使用绿色合成双金属金铜氧化物 (Au-CuO) 纳米粒子合成抗菌纳米复合材料.
- 评估这些纳米复合材料的抗菌活性和受控释放潜力.
- 研究Au-CuO纳米颗粒与微生物酶的结合机制.
主要方法:
- 使用植物提取物 (Cotoneaster,Laurus nobilis,Salvia officinalis) 的Au-CuO纳米颗粒的绿色合成.
- 纳米复合材料的制造与奇托/纳米奇托和P(MMAcoMAA).
- 使用FT-IR,XRD,SEM,UV-Vis,DLS和抗菌分析进行表征.
- 使用牛血清白蛋白 (BSA) 模型和分子对接模拟的受控释放研究.
主要成果:
- Au-CuO纳米粒子和纳米复合材料已成功合成和表征.
- 纳米复合材料显示出对大肠杆菌和黄金色杆菌的显著抗菌活性,以及对黑色杆菌的抗真菌活性.
- 在7天内观察到BSA的受控释放,基托基纳米复合材料的释放百分比很高.
- 分子对接表明Au-CuO NPs与微生物酶的结合 afinities,这表明了潜在的作用机制.
结论:
- 开发了一种新的环保纳米复合材料,具有强大的抗微生物特性和受控释放能力.
- 合成的Au-CuO纳米复合材料显示出在药物输送和抗菌治疗中的应用的前景.
- 该研究强调了绿色合成双金属纳米粒子在先进材料开发中的潜力.
更多相关视频
11:19Synthesis of Multi-walled Carbon Nanotubes Modified with Silver Nanoparticles and Evaluation of Their Antibacterial Activities and Cytotoxic Properties
Published on: May 10, 2018
10.2K
11:52Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro
Published on: April 21, 2023
2.9K
相关概念视频
Antimicrobial Effectiveness
2.1K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.1K
Antifungal Agents
89
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
89
